Form D · Biotechnology
BioRegenx Inc.
Chattanooga, TN · CIK 0001877104
Offering snapshot reported Apr 4, 2023 · SEC filing
- Reported sold
- $183K Offering amount: $3.6M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 18, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2023 | Initial | $183,000 | No comparison | 5 | SEC filing |
| Aug 6, 2021 | Initial | $615,456 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477942
Source: Form D, filed Apr 4, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sherri Adams | Director |
| Suzanne Bird | Director |
| Joseph S Bird | Promoter |
| Joseph Simmons Bird, Jr. | Director, Executive, Promoter |
| Robert Doran | Promoter |
| Gary Hennerberg | Director, Executive |
| Hitesh Juneja | Executive |
| Robert Long | Director, Executive, Promoter |
| William Resides | Director, Executive, Promoter |
| Hans Vink | Director, Executive, Promoter |
| Jody Walker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7407 Ziegler Road
Chattanooga, TN, 37421
Chattanooga, TN, 37421